MediciNova Files 2024 10-K
Ticker: MNOV · Form: 10-K · Filed: Feb 19, 2025 · CIK: 1226616
Sentiment: neutral
Topics: 10-K, pharmaceutical, annual-report
TL;DR
MNV filed its 2024 10-K. Full financials and biz update out.
AI Summary
MediciNova Inc. filed its 2024 10-K on February 19, 2025, reporting on its fiscal year ending December 31, 2024. The company, incorporated in Delaware and headquartered in La Jolla, CA, operates in the Pharmaceutical Preparations sector. Key financial details and operational updates for the fiscal year 2024 are presented in this comprehensive filing.
Why It Matters
This filing provides investors and stakeholders with a detailed overview of MediciNova's financial performance, strategic initiatives, and risk factors for the fiscal year 2024, crucial for understanding the company's current standing and future prospects.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, MediciNova faces inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 2024-12-31 — Fiscal Year End (Reporting period for the 10-K)
- 2025-02-19 — Filing Date (Date the 10-K was submitted)
Key Players & Entities
- MEDICINOVA INC (company) — Filer
- 2024-12-31 (date) — Fiscal Year End
- 2025-02-19 (date) — Filing Date
- LA JOLLA, CA (location) — Business Address
- 001-33185 (filing_id) — SEC File Number
FAQ
What is MediciNova Inc.'s primary business sector?
MediciNova Inc. operates in the Pharmaceutical Preparations sector, with SIC code 2834.
When did MediciNova Inc. file its 10-K report?
MediciNova Inc. filed its 10-K report on February 19, 2025.
What is the fiscal year end for the reported 10-K?
The fiscal year end for the reported 10-K is December 31, 2024.
Where is MediciNova Inc. headquartered?
MediciNova Inc. is headquartered at 4275 Executive Square, Suite 300, La Jolla, CA 92037.
What is the SEC file number for this 10-K filing?
The SEC file number for this 10-K filing is 001-33185.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on February 19, 2025 regarding MEDICINOVA INC (MNOV).